Results 241 to 250 of about 703,659 (314)

Comparative Effectiveness and Safety of Inebilizumab Versus Rituximab in AQP4‐IgG‐Positive NMOSD

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Rituximab (anti‐CD20, RTX) and inebilizumab (anti‐CD19, INE) represent B‐cell‐depleting therapies used for aquaporin‐4 antibody‐positive (AQP4‐IgG+) neuromyelitis optica spectrum disorder (NMOSD); however, direct comparative evidence remains limited.
Jie Lin, Binbin Xue, Dewei Xie, Jia Li, Juyuan Pan, Lanbing Zhu, Qiaowen Tong, Jing Lin, Ruofan Zhu, Xu Zhang, Junhui Xia, Xiang Li   +11 more
wiley   +1 more source

Reliability of urological telesurgery compared with local surgery: multicentre randomised controlled trial.

BMJ
Wang Y, Xia D, Xu W, Rexiati M, Zhao W, Huang Q, Shi T, Wang B, Wang S, Tai S, Qiao B, Zhang Y, Ye S, Zhang X, Mao J, Zhu Y, Wang H, Ma S, Yang C, Fu W, Song T, Ai Q, Song Y, Xu L, Yang G, Gao Y, Niu S, Guo J, Liu G, Xiang X, Liang C, Ma X, Li H, Zhang X, TeleS Research Group.   +34 more
europepmc   +1 more source

Effectiveness of a structured physiotherapy intervention on psychomotor and quality of life in children with autism spectrum disorder: A randomised controlled trial protocol. [PDF]

MethodsX
Alwi N, Zanudin A, Ahmad M, Mohamad NA.
europepmc   +1 more source

CAR T‐Cell Therapy in Neurology: A Scoping Review of Neuro‐Oncology, Autoimmune Diseases & Neurotoxicity

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Chimeric antigen receptor (CAR) T‐cell therapy has been investigated in neurological diseases, encompassing both central nervous system malignancies and autoimmune disorders, thereby extending its application beyond hematological cancers.
Omar Alqaisi, Mohammed Dibas, Patricia Tai, Ala Dibas, Osama Souied, Suhair Al‐Ghabeesh   +5 more
wiley   +1 more source

Petit volunteer protocol for loneliness alleviation in community-dwelling older adults in Japan: a randomised controlled trial. [PDF]

BMJ Open
Tomida K, Shimoda T, Nakajima C, Kawakami A, Shimada H.   +4 more
europepmc   +1 more source

Clinical Impact of NOTCH3 Variant Location After First Stroke in CADASIL

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Despite its monogenic origin, Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy exhibits marked variability in clinical expression and severity. Variants in the NOTCH3 gene, within epidermal growth factor‐like repeat domains 1–6 or 7–34, are known to influence disease onset, but their impact ...
Léa Aguilhon, Hugues Chabriat, Dominique Hervé, Stéphanie Guey, Sophie Tezenas Du Montcel, Juliette Ortholand   +5 more
wiley   +1 more source

Sustainable return-to-work in large organisations: feasibility of a multi-level cluster-randomised controlled trial

Munir F, Sinclair A, Davis O, Dawson J, Degerdon L, Delgadillo J, Kadam U, Yarker J.   +7 more
europepmc   +1 more source

The effect of daily aerobic cycling exercise on cannabis withdrawal: An inpatient randomised controlled trial. [PDF]

Sci Rep
Mills L, Rooney K, McCartney D, Murnion B, Arnold JC, Bhardwaj A, Haber PS, Arkell T, Richards E, McGregor IS, Lintzeris N.   +10 more
europepmc   +1 more source

Efficacy of Inebilizumab in N‐MOmentum Trial Participants With or Without Prior Immunosuppressants

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT This post hoc analysis examined the impact of prior immunosuppressants on the long‐term efficacy and safety of inebilizumab, a cluster of differentiation 19+ B‐cell–depleting monoclonal antibody, in participants with aquaporin‐4–seropositive neuromyelitis optica spectrum disorder from the N‐MOmentum trial (NTC02200770).
Bruce A. C. Cree, Beatrice Suero, Sarah Walsh, Romain Marignier, John W. Lindsey, Ho Jin Kim, Dewei She, Daniel Cimbora, Dustin Cavida, Friedemann Paul   +9 more
wiley   +1 more source

Gender differences in the influence of app-based mindfulness meditation on emotion regulation: a randomised controlled trial. [PDF]

Sci Rep
Adachi K, Kurosawa T, Takizawa R.
europepmc   +1 more source